The Board of Directors of Pacira BioSciences, Inc. has authorized a buyback plan on May 7, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.33 USD | -0.43% | +2.16% | -10.11% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.11% | 1.42B | |
+40.73% | 734B | |
+32.83% | 591B | |
-6.30% | 350B | |
+15.15% | 315B | |
+4.05% | 276B | |
+15.00% | 238B | |
+9.78% | 206B | |
-5.52% | 204B | |
+6.17% | 161B |
- Stock Market
- Equities
- PCRX Stock
- News Pacira BioSciences, Inc.
- Pacira BioSciences, Inc. authorizes a Buyback Plan.